Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 2Phase 4 1Phase 3 1Phase 1 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 33Gastrointestinal 13Thoracic 6Tumor-Agnostic 4CNS 3Sarcoma 1Head & Neck 1Gynecologic 1

Conditions

Brain Neoplasms 3Neoplasm Metastasis 2Meningeal Carcinomatosis 2Breast Neoplasms 2Glioblastoma 1

Interventions

Temozolomide 258Radiotherapy 147Bevacizumab 142Etoposide 68Cyclophosphamide 68Carboplatin 66Magnetic Resonance Spectroscopy 58Irinotecan 53Cisplatin 52Vincristine 45Filgrastim 43pembrolizumab 40Radiosurgery 36Nivolumab 36Radiation 34Topotecan 31Doxorubicin 30Specimen Handling 29sargramostim 28Lomustine 27Erlotinib Hydrochloride 27Peripheral Blood Stem Cell Transplantation 25Carmustine 25Thiotepa 24Everolimus 23Chemotherapy, Adjuvant 23Surgical Procedures, Operative 22Isotretinoin 22Ipilimumab 22Melphalan 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × trastuzumab deruxtecan × CNS × Clear all
NCT06048718 2026-05-08

TUXEDO-4

MedSIR

Phase 2 Active not recruiting
28 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT06058988 2026-02-23

Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
30 enrolled
CNS

Brain Neoplasms, Glioblastoma, Neoplasm Metastasis, Meningeal Carcinomatosis

NCT04420598 2025-06-24

DEBBRAH

MedSIR

Phase 2 Completed
41 enrolled 32 charts
BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡